Reimbursement Overview

The digene HPV Test detects 13 high-risk HPV types, responsible for nearly 100% of cervical cancer, and when combined with Pap screening programs as recommended by local guidelines can provide the highest assurance of detecting cervical disease at the earliest stage possible.

In many countries, the cost of the digene HPV Test is reimbursed when performed as a follow-up to abnormal Pap results. The digene HPV Test is also often covered by private health insurance schemes or can be added to regular healthcare programs for a small fee paid by the patient. Please ask your doctor or healthcare professional for advice.